News

The National Institutes of Health have granted $3 million to researchers at the University of Missouri Bond Life Sciences Center to study hepatitis B and develop new, effective treatment options.

In addition to licensed pharmacists, student pharmacists can play an important role in helping more Americans get vaccinated by participating in immunization campaigns throughout their communities.

A recent study details a case of a man with a confirmed Zika virus infection accompanied by papular descending eruption, petechiae on his palate, and hyperemic sclerae.

Researchers recently studied the way people expressed their pro-vaccination and anti-vaccination opinions on Facebook to understand how people discuss and spread these views.

In response to the serious global concern of growing drug-resistant “superbugs,” thirteen leading pharmaceutical companies have pledged to clean up pollution from company factories and prevent overuse of antibiotics.

A case of hepatitis A in a bakery employee at a Shop ‘N Kart located in Washington state has been confirmed by the Lewis County Public Health & Social Services Department.

The Centers for Disease Control and Prevention (CDC) has awarded scientists combating antibiotic resistance with more than $14 million in funding for new research and innovations by universities, nonprofits, and the business community.

The Joint Commission considers hand hygiene the most important intervention for preventing healthcare-associated infections, which are responsible for 75,000 deaths annually.

Consumer Reports recently evaluated more than 3,100 hospitals in the United States and found that about a third of them received a low rating for controlling infections from Clostridium difficile.

To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.

Pharmacists are critical to expanding access to pandemic vaccination. However, little is known about the relationships and planning activities between public health programs and pharmacies.

The World Health Organization (WHO) recently met to establish new guidelines for the Southern Hemisphere’s 2017 influenza virus vaccine.

Researchers have now identified virologic evidence of Zika virus in patients with Guillain-Barré syndrome, showing that the onset of the neurologic disorder can parallel the onset of systemic manifestations of the mosquito-borne infection.

Recently, WHO published a paper outlining their decade-long initiative to increase access and regulate production of the influenza vaccine.

As antibiotic-resistant bacteria continue to endanger public health, greater attention from health officials and new US federal funding aimed at fighting superbugs, signal a new urgency in this battle.

A voluntary recall has been initiated by Nurse Assist. All unexpired lots of IV Flush Syringes have been potentially linked to bloodstream infections from Burholderia cepacia.

Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.

Thanks to the recently approved $1.1 billion in federal funding to support Zika virus-related efforts, various government agencies are ramping up efforts to develop novel vaccines designed to prevent infection.

The FDA has released a warning on the risk of reactivation of hepatitis B virus in some patients receiving direct-action antivirals to treat hepatitis C infection.

Gonorrhea may soon become untreatable with current antibiotics, according to recent research presented at the Centers for Disease Control and Prevention's 2016 STD Prevention Conference.

The Centers for Disease Control and Prevention (CDC) has updated its interim guidance for “pre-pregnancy counseling” for Zika virus, just as new information regarding sexual transmission of the infection has been made available.

Gilead Science’s hepatitis C (HCV) drugs are forecasted to plummet in future years, according to a recent report.

A 44-year-old man from Britain could become the first patient ever to be cured of HIV, thanks to a groundbreaking new therapy developed to eradicate the virus.

The National Institutes of Health (NIH) has provided funding of $24 million this year to the Adolescent Medicine Trials Network for HIV/AIDS Interventions, the first clinical research group that will focus on youth infected by HIV.

Current traditional culture methods can take up to three days to identify bacteria and test antimicrobial resistances from a urine sample.

Recent research suggests those who are physically active may have a lower risk of bacterial infections than those who live a sedentary lifestyle.

Researchers at the University of Zurich and the University Hospital-Zurich have made a discovery that may contribute to the development of an effective HIV vaccine.

Can a vaccine be developed for human rhinovirus in its many forms? A new study suggests that it is possible.